FindMyKOL

Alan Dalkin, MD

Basic profile

University of Virginia

ORCIDOn fileNPIOn fileSign in to see identifiers
RegionCharlottesville, VA · SoutheastSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Last active 2000FindMyKOL typeFindMyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH funding1998–2000Why? →

Alan Dalkin is an Endocrinology/Metabolic physician affiliated with University of Virginia. OpenAlex indexes 83 publications with 3,838 citations (h-index 34).

Overview

Scholarship

indexed output and impact (OpenAlex)
83publications

Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.

3,838citations

Citations across these publications.

34h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
1NIH grants · 1998–2000

Federally funded research awards.

View funding ↓

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Hormonal (systemic)

    47.3%
    l-Thyroxine41.1%
    Levothyroxine Sodium77%Synthroid23%
    Part D≥123 patients
    l-Triiodothyronine3.9%
    Liothyronine Sodium100%
    Part D≥16 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    28.2%
    Insulin Analog12.3%
    Lantus Solostar23%Novolog Flexpen20%Humalog13%Lantus13%Novolog12%Humalog Kwikpen U-10011%Basaglar Kwikpen U-1009%
    Part D<11 patients
    Biguanide (metformin)7.8%
    Metformin Hcl Er56%Metformin Hcl44%
    Part D≥19 patients

    + 6 more classes in this area

  • Cardiovascular

    17.9%
    Statin6.9%
    Atorvastatin Calcium68%Rosuvastatin Calcium33%
    Part D<11 patients
    ACE inhibitor3%
    Lisinopril100%
    Part D≥15 patients

    + 5 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 1998–2000 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”